On June 5, 2013, Corcept Therapeutics Incorporated announced the retirement of Robert L. Roe, M.D., President and Secretary, effective December 31, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.49 USD | +1.34% |
|
+8.16% | +0.03% |
14/06 | Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva... | ![]() |
14/06 | Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.03% | 3.38B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- CORT Stock
- News Corcept Therapeutics Incorporated
- Corcept Therapeutics Incorporated Announces Retirement of Robert L. Roe as President and Secretary, Effective December 31, 2013